$BIIB News Stocks close mostly higher after jobs report

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$BIIB News

Stocks close mostly higher after jobs report beats forecasts: stock market live blog recap 5:03 p.m. March 7, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
Utility stocks gain as Treasury yields lag 5:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Biogen Idec investors focus on positive, ignore outlook for 2014 3:02 p.m. Jan. 29, 2014 - Russ Britt
Biogen profit jumps on MS treatment revenue 8:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 9:01 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 4:55 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 5:23 p.m. Jan. 14, 2014 - Sue Chang
Beam up on Suntory deal; Elliott report lifts Juniper 5:18 p.m. Jan. 13, 2014 - Sue Chang
Biogen, Sangamo partner on hemoglobin therapies 10:39 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 5:25 p.m. Jan. 8, 2014 - Sue Chang
Goldman's biotech downgrade and the new consensus 12:53 p.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 1:29 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 1:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 3:33 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 2:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 2:19 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 5:56 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 5:24 p.m. Nov. 22, 2013 - Polya Lesova


Aegerion Pharmaceuticals (AEGR) Soars: Stock Rises 10.6% - Tale of the Tape 9:39 a.m. Today - Zacks.com
Zacks Rank #1 Additions for Monday - Tale of the Tape 9:30 a.m. Today - Zacks.com
Emergent Beats on Earnings & Revenues, Shares Up - Analyst Blog 9:10 a.m. Today - Zacks.com
Emergent BioSolutions (EBS) Soars: Stock Rises 8.6% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Next Stop for the Nasdaq: 5000 3:33 a.m. March 8, 2014 - Barrons.com
Highflying Drug, Biotech Stocks Take Rare Drubbing 4:49 p.m. March 7, 2014 - Investors Business Daily
Market Wrap For March 7: Markets Cap Off Positive Week With Small Gains 3:31 p.m. March 7, 2014 - benzinga.com
Profit from Orphan Drugs: 3 Choices (Revised) - Analyst Blog 2:33 p.m. March 7, 2014 - Zacks.com
Sangamo Soars on Positive Data - Analyst Blog 11:50 a.m. March 7, 2014 - Zacks.com
Spectrum Pharma Posts Lower Y/Y Q4 Earnings - Analyst Blog 10:00 a.m. March 7, 2014 - Zacks.com
Sangamo Biosciences (SGMO) Worth Watching: Stock Surges 17.1% - Tale of the Tape 9:25 a.m. March 7, 2014 - Zacks.com
Karyopharm Therapeutics, Inc. (KPTI) Catches Eye: Stock Jumps 13.9% - Tale of the Tape 8:44 a.m. March 7, 2014 - Zacks.com
Biogen-Eisai Ink Alzheimer's Deal - Analyst Blog 4:45 p.m. March 6, 2014 - Zacks.com
Biogen upgraded 4:06 p.m. March 6, 2014 - Seeking Alpha
Insider Trading Alert - BIIB, VRX And AME Traded By Insiders 1:00 p.m. March 6, 2014 - TheStreet.com
3 Stocks Raising The Drugs Industry Higher 12:02 p.m. March 6, 2014 - TheStreet.com
Today's Momo Momentum Stock Is Biogen Idec (BIIB) 10:07 a.m. March 6, 2014 - TheStreet.com
Oncothyreon (ONTY) Jumps: Stock Moves 9.9% Higher - Tale of the Tape 9:46 a.m. March 6, 2014 - Zacks.com
Strength Seen in ANI Pharmaceuticals, Inc. (ANIP): Stock Soars 15.9% - Tale of the Tape 8:44 a.m. March 6, 2014 - Zacks.com
Bull of the Day: Quintiles (Q) - Bull of the Day 2:59 a.m. March 5, 2014 - Zacks.com


RBCC: Analyst Rates n3D a Leading Stakeholder in Explosive Bioprinting Industry 5:00 a.m. March 6, 2014 - BusinessWire - BZX
Global Biosimilars Market 2014-2018 10:28 a.m. Feb. 27, 2014 - PR Newswire - PRF
Critical Alerts For Walter Energy, Regeneron, Biogen Idec, Red Hat, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. Feb. 27, 2014 - PR Newswire - PRF
WuXi PharmaTech Announces Appointment of Dr. Hua Mu to Head Product Development Service and Partnership Business Unit 9:33 a.m. Feb. 26, 2014 - PR Newswire - PRF
RBCC Increases Foothold in 3D Bioprinting Market 7:49 a.m. Feb. 26, 2014 - BusinessWire - BZX
Biogen Idec to Present at the Cowen & Company 34th Annual Health Care Conference 4:01 p.m. Feb. 25, 2014 - BusinessWire - BZX
SciQuest Customers to Discuss Procurement Transformation in Action at NextLevel 2014 8:35 a.m. Feb. 24, 2014 - BusinessWire - BZX
RBCC: New Innovations Spur Demand for 3D Printing in Medicine 5:00 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 2014 RBC Capital Markets’ Healthcare Conference 4:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
New Product Puts RBCC on Leading Edge of Organ Regeneration Research 5:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
William D. Young To Retire From Biogen Idec’s Board of Directors 1:50 p.m. Feb. 15, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion 5:00 a.m. Feb. 6, 2014 - BusinessWire - BZX
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 9:33 a.m. Feb. 3, 2014 - BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 8:53 a.m. Feb. 3, 2014 - BusinessWire - BZX
RBCC: 3D Bioprinting Tech Ushers in Future of Medicine 8:40 a.m. Feb. 3, 2014 - BusinessWire - BZX
Ignyta Appoints Matthew Onaitis as General Counsel 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Biogen Idec Foundation Awards Museum of Science $2.5 Million to Support Hall of Human Life 8:30 a.m. Jan. 30, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Protecting Shareholder Rights: iRhythm Technologies Update

Updated Category News Views 104

Understanding Your Rights as a Shareholder For shareholders of iRhythm Technologies, Inc. (NASDAQ: IRTC), it's imperative to be proactive regarding your rights. Engaging with legal experts can significantly empower your ability to affect change and seek justice for any personal or collective grievances stemming from corporate actions. Why Shareholder Action is Crucial...

Continue Reading
Discover the New Credit Risk IQ and its Industry Insights

Updated Category News Views 138

Introducing Credit Risk IQ Credit Benchmark, a leader in delivering essential credit risk data and analytics, has launched an exciting new platform called Credit Risk IQ. This online portal features an extensive library of over 5,000 free monthly reports that explore credit trends at both industry and sector levels. The insights found in these reports are invaluable for...

Continue Reading
9Rooftops Retained as Marketing Agency for South Carolina Tourism

Updated Category News Views 233

9Rooftops Reappointed for South Carolina Tourism Marketing 9Rooftops, known for its innovative marketing strategies, has been reappointed as the Marketing and Advertising Agency of Record for the South Carolina Department of Parks, Recreation & Tourism (SCPRT). This marks a continued partnership aimed at showcasing the beauty and attractions of South Carolina. A...

Continue Reading
Kyivstar Enhances Digital Services with AI Cloud Solutions

Updated Category News Views 203

Kyivstar Revolutionizes Cloud Services with AI Integration Kyivstar Group Ltd (Nasdaq: KYIV; KYIVW) has embarked on an ambitious journey to strengthen digital services within Ukraine. The company has officially announced the integration of groundbreaking artificial intelligence (AI) technologies into its cloud platform, Kyivstar Cloud. This advancement is pivotal for all...

Continue Reading
Akeso Advances Cancer Care with Ivonescimab Phase III Trial Launch

Updated Category News Views 171

Akeso Launches Phase III Trial for Ivonescimab in SCLC Akeso, Inc. (9926.HK) recently announced an exciting milestone in cancer treatment with the first patient being dosed in its Phase III clinical trial. This multicenter, randomized, and double-blind study, named AK112-311/HARMONi-9, evaluates the efficacy and safety of ivonescimab, a unique bispecific antibody that...

Continue Reading